Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Anyone who has spent five minutes with Paula can attest to her lust for life
Product Specifications Product Name: FOXO4-DRI Alternate Name: Proxofim Strength: 10mg Research Information Purity: 99% Appearance: Lyophilised Powder Category: Senolytic Research Peptide Research Reference Parameters Laboratory Use Only Peptide Type: Senolytic Peptide Research Focus: Cellular Senescence & Healthy Ageing Primary Pathway: FOXO4p53 Interaction Disruption For laboratory research only
PubMed laboratory research record [PMID: 29509368] PubMed record related to this compound for laboratory literature review
Lintner, K., & Peschard, O
Currently, NS-2330 is in Phase II clinical trials for AD and undergoing a Phase II tolerability trial for PD patients with dyskinesia
